Drug Discovery Technologies

Summary

Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D. These technologies include bioanalytical instruments, genomics, pharmacogenomics, combinatorial chemistry, biochip, proteomics, bioinformatics and high throughput screening (HTS). Use of emerging technologies in drug discovery such as lab on a chip (LOC), nanotechnology and RNA interference (RNAi) is increasing at a rapid pace given their ability to expedite, and improve the efficiency of drug discovery processes and reducing time-to-market.

These and other market data and trends are presented in "Drug Discovery Technologies: A Global Update of Market Trends & Opportunities" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Global Market Overview and Outlook
  • Drug Discovery Outsourcing - A Necessity
• 3.An Overview of Key Emerging Technologies
  • Bioinformatics
  • Pharmacogenomics
  • Theragnostics
  • Targeted Therapy
  • Mass Spectrometry - A New Catalyst for Technological Developments
  • Tandem Lc/Ms Market
  • Ft-Ms Market
  • Maldi-Tof Market
  • Gc/Ms Market
  • Magnetic Ms Market
• 4.Market Trends
  • New Technologies Fire up Drug Discovery Market
  • Obesity Related Diseases Driving Drug Discovery Research
  • Biochips Change Face of Drug Discovery
  • Genomics and Proteomics Gaining Prominence
  • Genomics Drives Bioinformatics Growth in Drug Discovery
  • Market Scenario of Human Genome Sciences (Hgs)
  • International Initiatives Expand Proteomics
• 5.Product Facts
  • Bioanalytical Instruments
  • Nuclear Magnetic Resonance
  • Mass Spectroscopy
  • Microplate Readers
  • Chemotherapy Instruments
  • High Throughput Screening (Hts)
  • Genomics
  • Proteomics
  • Bioinformatics
  • Biochip15pharmacogenomics
  • Other Drug Discovery Technologies
• 6.Corporate Developments
  • Affymetrix Acquires USB Corp
  • Roche Acquires Ventana Medical Systems
  • Bruker Biosciences Acquires Bruker Biospin Group
  • Takeda Signs Agreement to Take over Millennium
  • Implant Sciences to Acquire Ion Metrics
  • Nascacell and Archemix Expand Partnership for Aptamer-Based Drugs
  • Discoverx and Cosmo Bio Sign Distribution Agreement
  • Zydus Cadila Enters into Collaboration with Prolong Pharmaceuticals
  • Psychogenics Enters into Drug Discovery Agreement with Dainippon
  • Zydus Cadila Collaborates with Karo Bio
  • Dr. Reddy's Signs Collaboration Agreement with 7tm Pharma
  • Synamatix Enters into Collaboration with Universiti Malaysia
  • Monogram Enters into Exclusive Collaboration Agreement with Avexa
  • Caliper Life Sciences Collaborates with Horizon Discovery
  • Galapagos Signs Collaborative Agreement with Allergan for Drug Discovery
  • Sigma-Aldrich Inks Exclusive Distributionpartnership with Atlas Antibodies
  • Psychogenics Enters into New Agreement with Eli Lilly
  • Biofocus Dpi Extends Contract with Lilly
  • Invitrogen to Collaborate with Tecan
  • Ranbaxy Forms New Drug Discovery Company
  • Affymetrix Introduces Cytogenetic Solution
  • Affymetrix Introduces Dmet Early Access Solution
  • Affymetrix Microarray Platform to Feature in Pathwork's Diagnostic Test
  • Bio-Rad Laboratories Rolls out Vasculitis Kit for Bioplex 2200 System
  • Perkinelmer Develops Products for High-Throughput Screening
  • Tecan to Introduce Multimode Microplate Reader- Infinite M1000
  • Tripos International Launches Sybyl8.0
  • Eli Lilly Acquires Icos Corporation
  • Cmc Announces Acquisition of Icos Biologics Facility from Eli Lilly
  • Surmodics Acquires Brookwood
  • Commonwealth Biotechnologies Acquires Tripos Discovery Research
  • Vastox Acquires Dextra Laboratories and Daniolabs
  • Wyeth Completes The Acquisition of Haptogen
  • Roche Takes over Nimblegen
  • Amri Acquires Pharmaceutical Manufacturing Units in India
  • Agilent Technologies Acquires Stratagene
  • Astrazeneca Takes over Medimmune
  • Ocimum Acquires Gene Logic's Genomics Business
  • Newsham Genetics Acquires Monsanto Choice Genetics
  • Evotec Takes over Combinature Biopharm's Drug Discovery Unit
  • Bioserve Takes over Genomics Collaborative
  • Thomson Takes over Unleashed Informatics Ltd
  • Thomson Completes Acquisition of Prous Science
  • Mds Acquires Molecular Devices
  • Evotec to Take over Renovis
  • Ecopia Merges with Caprion
  • Thallion Sells Majority Interest in Caprion Proteomics Business
  • Affymetrix Enters into Licensing Agreement with Empire Genomics
  • Graffinity Pharmaceuticals Signs Drug Discovery Agreement with Amgen
  • Arqule Signs License Deal with Kyowa Hakko
  • Orion and Chemdiv Enter into Collaborative Deal
  • Graffinity Enters into Drug Discovery Collaboration with Pfizer
  • Tata Enterprise Establishes Pharmaceutical Development Centre
  • Nicholas Piramal Collaborates with Merck
  • Eksigent Signs Distribution Agreement with Interface Engineering
  • Mds Pharma Expands Chinese Lab Operations
  • Abbott and Caprion Proteomics Extends Partnership
  • Agilent Technologies and Bionanomatrix Enters into Collaboration
  • Evotec Extends Partnership with Boehringer Ingelheim
  • Evotec and Interprotein Enter into Collaboration
  • Galapagos Forms Drug Innovation Alliance with Astrazeneca
  • Proteome Systems and Bd Enter into An Agreement
  • Galapagos Extends Drug Innovation Partnership with Amgen
  • Dimerix Collaborates with Ncds
  • Ace Biosciences and Clc Bio Enter Intocollaborative Agreement
  • Ambrx Enters into Strategic Agreement with Merck & Co
  • Galapagos and Cystic Fibrosis Collaborate for Drug Discovery
  • Biodiscovery Collaborates with Illumina
  • Jubilant & Forest Enter into Partnership Deal
  • Invitrogen Corporation Signs Agreement with Emiliem to Screen Kinase Inhibitors
  • Amri Establishes New Center in India
  • Bio-Rad Laboratories Unveils In2it A1c Analyzer for Diabetic Patients
  • Charles River Launches Endosafe-McsEndotoxin Detection System
  • Invitrogen Launches Human Embryonic Stem Cells Monitoring Kit
  • Sigma-Aldrich Introduces Proteomics Dynamic Range Standard
  • Molecular Devices Develops Arcturus (Xt) Lmc Instrument
  • Fujitsu's Biosciences Renames Cache Software and Releases Scigress Explorer/li>
  • Tripos International Unveils Topomer Comfa
  • Tripos International Launches Topomer Search
• 7.Major Players
  • Abbott Laboratories (US)
  • Affymetrix Inc. (US)
  • Agilent Technologies Inc. (US)
  • Albany Molecular Research, Inc. (US)
  • Amersham Biosciences (US)
  • Applera Corporation (US)
  • Arqule Inc. (US)
  • Astrazeneca (UK)
  • Bd Biosciences (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Biosciences Group (Japan)
  • Caliper Life Sciences, Inc. (US)
  • Capital Genomix (US)
  • Caprion Proteomics (Canada)
  • Charles River Laboratories International, Inc. (US)
  • Chembridge Corporation (US)
  • Decode Genetics, Inc (Iceland)
  • Evotec Ag (Germany)
  • Galapagos Nv (Belgium)
  • Incyte Corporation (Formerly Incyte Genomics Inc.) (US)
  • Infinity Pharmaceuticals, Inc. (US)
  • Invitrogen Corporation (US)
  • Medarex, Inc. (US)
  • Merck & Co., Inc. (US)
  • Millennium Pharmaceuticals, Inc. (US)
  • National Center for Drug Screening (China)
  • Perkinelmer, Inc. (US)
  • Pharmacopeia Inc. (US)
  • Proteome Systems (Australia)
  • Quantum Pharmaceuticals (Russia)
  • Shimadzu Corporation (Japan)
  • Sigma-Aldrich (US)
  • Tecan Group (Switzerland)
  • Thallion Pharmaceuticals, Inc. (Canada)
  • Tripos International (US)
• 8.Market Analytics
• 9.The United States
  • Overview
  • US Leads The World High Throughput Screening (Hts) Market
• 10.Canada
• 11.Japan
  • Japan Resembles US in Life Science Research
• 12.Europe
  • An Overview of Pharmacogenomics and Personalized Medicine
  • Emerging Trends in Proteomics Technology
  • Protein Classification
  • Protein Separation
  • Market Trends
  • European Market for Drug Discovery Tools
  • UK Government Supports Proteomics Research
  • Drug Discovery Outsourcing in Europe
• 13. Rest of World
  • Asia-Pacific
  • Emerging Opportunities
  • Cost Advantage in Asia Attracts Global Drug Discovery Industry
  • Regulations Affect Asia-Pacific Drug Discovery Market
  • India
  • Bioinformatics Market in India
  • Scope and Demand for Bioinformatics Market to Expand Significantly by 2010
  • Discovery of Therapeutic Molecules - A New Buzzword for Growth Acceleration
• Exhibits
  • Table 1: Global Drug Discovery Technologies Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 2: Percentage Breakdown of Global Drug Discovery Technologies Market by Region for The Years 2008 &
  • Table 3: Global Bioanalytical Instruments Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 4: Percentage Breakdown of Global Bioanalytical Instruments Market by Region for The Years 2008 &
  • Table 5: Global High Throughput Screening (Hts) Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 6: Percentage Breakdown of Global High Throughput Screening (Hts) Market by Region for The Years 2008 &
  • Table 7: Global Biochip Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 8: Percentage Breakdown of Global Biochip Market by Region for The Years 2008 &
  • Table 9: Global Proteomics Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 10: Percentage Breakdown of Global Proteomics Market by Region for The Years 2008 &
  • Table 11: Global Genomics Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 12: Percentage Breakdown of Global Genomics Market by Region for The Years 2008 &
  • Table 13: Global Bioinformatics Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 14: Percentage Breakdown of Global Bioinformatics Market by Region for The Years 2008 &
  • Table 15: Global Pharmacogenomics Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 16: Percentage Breakdown of Global Pharmacogenomics Market by Region for The Years 2008 &
  • Table 17: Global Other Drug Discovery Technologies Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 18: Percentage Breakdown of Global Other Drug Discovery Technologies Market by Region for The Years 2008 &
  • Table 19: The US Market for Drug Discovery Technologies Market by Type: 2007-2015 (Sales in US$ Million)
  • Table 20: Percentage Breakdown of The US Market for Drug Discovery Technologies Market by Type for The Years 2008 &
  • Table 21: The Canadian Market for Drug Discovery Technologies Market by Type: 2007-2015 (Sales in US$ Million)
  • Table 22: Percentage Breakdown of The Canadian Market for Drug Discovery Technologies Market by Type for The Years 2008 &
  • Table 23: The Japanese Market for Drug Discovery Technologies Market by Type: 2007-2015 (Sales in US$ Million)
  • Table 24: Percentage Breakdown of The Japanese Market for Drug Discovery Technologies Market by Type for The Years 2008 &
  • Table 25: The European Market for Drug Discovery Technologies Market by Type: 2007-2015 (Sales in US$ Million)
  • Table 26: Percentage Breakdown of The European Market for Drug Discovery Technologies Market by Type for The Years 2008 &
  • Table 27: The Rest of World Market for Drug Discovery Technologies Market by Type: 2007-2015 (Sales in US$ Million)
  • Table 28: Percentage Breakdown of Rest of World Market for Drug Discovery Technologies Market by Type for The Years 2008 &
• Companies Profiled